Anti-RPL13A Antibody

This polyclonal antibody from Antibodies.com targets RPL13A, a ribosomal protein component of the 60S subunit that participates in cytosolic protein synthesis and contributes to translational silencing of selected mRNAs via the gamma-interferon-activated inhibitor of translation (GAIT) pathway. Raised in rabbit and affinity-purified, the unconjugated reagent is supplied as 100 µl of liquid and is validated for Western blot, immunohistochemistry, and immunofluorescence workflows on human samples. It binds the endogenous ribosomal target, supporting detection of ribosome-associated fractions in cell and tissue lysates. Researchers commonly deploy it as a normalization control for ribosomal loading across comparative expression studies and as a marker when probing GAIT-mediated translational regulation in inflammatory and antiviral response models.